FDA 483 - Pharbil Waltrop Gmbh - June 06, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Pharbil Waltrop Gmbh in Waltrop, Germany, revealed significant deficiencies in the firm's manufacturing and quality control systems. Observations included incomplete batch production records, specifically regarding product reconciliation, and a failure of the quality unit to detect discrepancies in test data between laboratory journals and certificates of analysis. These findings indicate a lack of adequate control over critical production and quality processes.
ID · 03ff22ea-a3b6-449c-8282-241b63a1c29d